ORTHOPEDIATRICS CORP

ORTHOPEDIATRICS CORP

OrthoPediatrics produces medical devices for children with orthopedic conditions

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Orthopediatrics Corp's stock, expecting its value to rise significantly.

Above Average

Financial Health

Orthopediatrics Corp is performing well with strong revenue, profits, and cash flow generation.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring KIDS

The Post-Pandemic Pediatric Pivot

The Post-Pandemic Pediatric Pivot

The FDA's potential withdrawal of Pfizer's COVID vaccine for young children is reshaping the pediatric pharmaceutical landscape. This regulatory shift could create a significant market opening for other drugmakers focused on pediatric vaccines and therapies.

Published: August 13, 2025

Explore Basket
Pediatric Vaccine Rollout

Pediatric Vaccine Rollout

This carefully selected group of stocks represents companies positioned to benefit from the full FDA approval of COVID-19 vaccines for at-risk children. Our professional analysts have identified opportunities across the entire value chain, from vaccine manufacturers to healthcare providers and clinical research organizations.

Published: July 11, 2025

Explore Basket
Next Generation Economy

Next Generation Economy

Tap into the powerful world of parental spending with these carefully selected stocks. Professional investors have curated this collection of companies that serve children from birth through adolescence, capturing one of the most resilient consumer markets regardless of economic conditions.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Child-focused devices

Specialist products address paediatric needs and can command niche demand, though market uptake varies by surgeon familiarity and evidence.

⚑

Innovative pipeline

New product introductions and clinical data may drive adoption, but development and regulatory hurdles can delay commercial benefits.

🌍

Global expansion potential

International distribution offers growth opportunities, balanced by reimbursement differences and the costs of scaling operations.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions